Nasopharyngeal dendritic cell sarcoma, not otherwise specified, in a 34-year-old man.

William B. Horton, David A. Joyner, William P. Daley, Karen Pitman, Majid Khan

Research output: Contribution to journalArticle

Abstract

Dendritic cell sarcoma, not otherwise specified (NOS), is an entity that is poorly defined because of its rarity and poorly understood pathogenesis. It is characterized by positive immunohistochemical staining for S-100 and CD1a, along with an absence of cytoplasmic Birbeck granules on electron microscopy. We report the case of a surgically inaccessible nasopharyngeal dendritic cell sarcoma, NOS, in a 34-year-old man. Treatment with chemotherapy along with adjuvant radiation therapy was successful in decreasing the size of the nasopharyngeal mass, and the patient remained free of any evidence of recurrence nearly 5 years after treatment.

Original languageEnglish (US)
JournalEar, nose, & throat journal
Volume90
Issue number6
StatePublished - Jun 2011
Externally publishedYes

Fingerprint

Sarcoma
Dendritic Cells
Cytoplasmic Granules
Electron Microscopy
Radiotherapy
Staining and Labeling
Recurrence
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Nasopharyngeal dendritic cell sarcoma, not otherwise specified, in a 34-year-old man. / Horton, William B.; Joyner, David A.; Daley, William P.; Pitman, Karen; Khan, Majid.

In: Ear, nose, & throat journal, Vol. 90, No. 6, 06.2011.

Research output: Contribution to journalArticle

@article{62cb8bdb7e78471d8f122061e3fc04e1,
title = "Nasopharyngeal dendritic cell sarcoma, not otherwise specified, in a 34-year-old man.",
abstract = "Dendritic cell sarcoma, not otherwise specified (NOS), is an entity that is poorly defined because of its rarity and poorly understood pathogenesis. It is characterized by positive immunohistochemical staining for S-100 and CD1a, along with an absence of cytoplasmic Birbeck granules on electron microscopy. We report the case of a surgically inaccessible nasopharyngeal dendritic cell sarcoma, NOS, in a 34-year-old man. Treatment with chemotherapy along with adjuvant radiation therapy was successful in decreasing the size of the nasopharyngeal mass, and the patient remained free of any evidence of recurrence nearly 5 years after treatment.",
author = "Horton, {William B.} and Joyner, {David A.} and Daley, {William P.} and Karen Pitman and Majid Khan",
year = "2011",
month = "6",
language = "English (US)",
volume = "90",
journal = "Ear, Nose and Throat Journal",
issn = "0145-5613",
publisher = "Medquest Communications LLC",
number = "6",

}

TY - JOUR

T1 - Nasopharyngeal dendritic cell sarcoma, not otherwise specified, in a 34-year-old man.

AU - Horton, William B.

AU - Joyner, David A.

AU - Daley, William P.

AU - Pitman, Karen

AU - Khan, Majid

PY - 2011/6

Y1 - 2011/6

N2 - Dendritic cell sarcoma, not otherwise specified (NOS), is an entity that is poorly defined because of its rarity and poorly understood pathogenesis. It is characterized by positive immunohistochemical staining for S-100 and CD1a, along with an absence of cytoplasmic Birbeck granules on electron microscopy. We report the case of a surgically inaccessible nasopharyngeal dendritic cell sarcoma, NOS, in a 34-year-old man. Treatment with chemotherapy along with adjuvant radiation therapy was successful in decreasing the size of the nasopharyngeal mass, and the patient remained free of any evidence of recurrence nearly 5 years after treatment.

AB - Dendritic cell sarcoma, not otherwise specified (NOS), is an entity that is poorly defined because of its rarity and poorly understood pathogenesis. It is characterized by positive immunohistochemical staining for S-100 and CD1a, along with an absence of cytoplasmic Birbeck granules on electron microscopy. We report the case of a surgically inaccessible nasopharyngeal dendritic cell sarcoma, NOS, in a 34-year-old man. Treatment with chemotherapy along with adjuvant radiation therapy was successful in decreasing the size of the nasopharyngeal mass, and the patient remained free of any evidence of recurrence nearly 5 years after treatment.

UR - http://www.scopus.com/inward/record.url?scp=80051853124&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051853124&partnerID=8YFLogxK

M3 - Article

VL - 90

JO - Ear, Nose and Throat Journal

JF - Ear, Nose and Throat Journal

SN - 0145-5613

IS - 6

ER -